OvaScience (NSDQ:OVAS) said today it closed a $53.8 million funding round as it looks to expand its Augment treatment in Japan and Canada and support pre-commercial activities for its OvaPrime and OvaTure treatments. OvaScience’s Augment fertility treatment is designed to enhance in vitro fertilization by improving the health of a woman`s eggs, the company said. The treatment draws […]
OvaScience preps offering to support Augment expansion
OvaScience (NSDQ:OVAS) said today it is opened a new offering of stock as it looks to expand its Augment treatment in Japan and Canada and support pre-commercial activities for its OvaPrime and OvaTure treatments. OvaScience’s Augment fertility treatment is designed to enhance in vitro fertilization by improving the health of a woman`s eggs, the company said. The […]
CardioInsight names Patrick Wethington new CEO | Personnel Moves
Boston Scientific CFO Jeffrey Capello joins board of OvaScience | Personnel Moves
Boston Scientific (NYSE:BSX) executive vice president and chief financial officer Jeffrey Capello joined the board of directors at OvaScience, a Boston, Mass.-based start up developing infertility treatments.
Capello began working at Boston Scientific in 2008, landing the CFO seat in 2010. He oversees the company’s global finance, information systems, business development and corporate strategy functions.
